PPD

Pharmaceutical Product Development (PPD), founded in 1985, operates as a premier global contract research organization (CRO). The company specializes in comprehensive drug discovery, development, and lifecycle management services. PPD serves a broad spectrum of clients, including major pharmaceutical and biotechnological firms, medical device manufacturers, academic institutions, and government organizations worldwide. With a robust operational footprint spanning 60 locations, PPD facilitates complex research initiatives across diverse therapeutic areas.

The organization's strength lies in its extensive workforce of over 10,000 dedicated professionals. This global team comprises scientists, clinicians, and project managers who deliver integrated drug development solutions. Their expertise covers the entire clinical research continuum, from early-stage discovery through late-stage clinical trials and post-market support. To gain insight into the human capital driving these advancements, Meet PPD's team and discover the collective expertise dedicated to client success and patient outcomes.

Financially, PPD reported a substantial revenue of $7.4 billion, underscoring its significant market share and operational capacity. The company offers a wide array of services, including laboratory services, clinical development, and regulatory consulting, supporting biopharmaceutical innovation. For a deeper dive into its financial performance and metrics, Explore financial highlights. PPD navigates a competitive landscape alongside industry leaders such as IQVIA and Syneos Health, consistently focusing on accelerating the delivery of new therapies to patients globally.